维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：期刊名="AapsJ"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	DNA-based therapeutics and DNA delivery systems:acomprehensive review显示文摘	Siddhesh D David G Diang J	2005	AAPSJ2005，7，1：	1
2	Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease显示文摘	Liu B	2006	AAPSJ2006，8，：	1
3	Mechanisms ofmethamphetamine-induced dopaminergic neurotoxicity 显示文摘	Riddle EL Fleckenstein AE Hanson GR	2006	AapsJ2006，8，2：	1
4	DNA- based the rapeutice and DNA delicery systems acorn prehensive review 显示文摘	Siddhesh D David C Diang J	2005	AAPSJ2005，7，1：	1
5	Unbiased membrane permeability parameters for gabapentin using boundary layer approach 显示文摘	Madan J Chawla G Arora V	2005	AAPSJ2005，7，1：	1
6	Drug discovery from natural sources 显示文摘	Chin Y Ba\|unas M J Chai HB	2006	AAPSJ2006，8，2：	1
7	Accelerating drug development using biomarkers: a case study with sitagliptin, a novel DPP4 inhibitor for type 2 diabetes显示文摘	KRISHNA R HERMAN G WAGNERJA	2008	AAPSJ2008，10，2：	1
8	Microdialysis as a tool in local pharmacedynamics显示文摘	Li Y Peris J Zhong L	2006	AAPSJ2006，8，2：	1
9	Biomarkers for drug-induced renal damage and nephrotoxicity-an ovmwiew for applied toxicology 显示文摘	FUCHS TC HEWITT P	2011	AapsJ2011，13，4：	1
10	Cytochrome P450sand other en-zymes in drug metabolism and toxicity显示文摘	Guengerich FP	2006	AAPSJ2006，8，1：	1
11	Nonviral gene delivery: what we know and what is next显示文摘	Gao X Kim KS Liu D	2007	AAPSJ2007，9，：	1
12	Pilot investigation on long-term subcutaneous microdialysis: proof of principle in hu- mans显示文摘	Simmel F Kirbs C Erdogan Z	2013	AAPSJ2013，15，1：	1
13	In sights into the substrate specificity, inhibitors, reg/:Lation, and polymorphisms and the clinical impact of human eytochrome P450 1A2 显示文摘	ZHOUS F YANG L P ZHOU Z W	2009	AAPSJ2009，11，3：	1
14	Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2显示文摘	Zhou SF Yang LP Zhou ZW	2009	AapsJ2009，11，3：	1
15	The twofoldadvantage of the amorphous form as an oral drug deliverypractice for lipophilic compounds: increased apparentsolubility and drug flux through the intestinal membrane 显示文摘	Dahan A Beig A Ioffe-Dahan V	2013	AAPSJ2013，15，2：	1
16	Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers 显示文摘	Shur J Lee S Adams W	2012	AAPSJ2012，14，4：	1
17	DNA-based therapeutics and DNA delivery systems:a comprehensive review显示文摘	Siddhesh D David G Diang J	2005	AAPSJ2005，7，1：	1
18	Small molecule modifiers of the microRNA and RNA i~terference pathway显示文摘	Deiters A	2010	AAPSJ2010，12，1：	1
19	Mechanisms of metham?phetamine-induced dopaminergic neurotoxicity显示文摘	Riddle EL Fleckenstein AE Hanson GR	2006	AapsJ2006，8，2：	1
20	Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate 显示文摘	Patel AR Vavia PR	2007	AAPSJ2007，9，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示